Dr. Elizabeth Worthey has degrees in Immunology, Genomics, and Genetics and has studied at leading Universities including Glasgow, Birmingham, Oxford, and Stanford Universities, Imperial College London, and the University of Washington. She has more than 20 years of experience in the development and application of tools, methods, and algorithms to extract knowledge from large genomics and other research and clinical datasets. Dr. Worthey performed the first analyses that successfully used genomic data to change medical treatment and together with colleagues built the first Genomic Medicine program in the world. She has been invited to give talks around the world on this topic. At HudsonAlpha she is the head of the Software Development and Informatics (SDI) Group.

Her group has three distinct missions: 1) to support the Institutional Informatics needs within HudsonAlpha by developing software for analysis of genomics datasets and through application of these tools to turn big data into generalizable research knowledge, 2) to support the Clinical Informatics needs of the various HudsonAlpha clinical entities to turn genomic data into knowledge with clinical utility, and 3) to undertake novel research into the genetic underpinnings of rare and more common disease including cancer in order to provide research findings and clinically useful data for human diseases.